For all the new readers who’ve joined since my post about effective altruism and elections, welcome! I’m now back to my usual biology beat, although this one is also influenced by my effective altruism bent. After all, one of the major reasons I started a biotech company was because I thought it was a morally good thing to do, a standpoint heavily influenced by EA. Now, onto the essay.
This was really interesting, thanks for the writeup! The idea of targeting animal drug approval before humans seem almost obvious after reading this, making me think that either 1) I'm missing some downsides, or 2) the drug development market just isn't very efficient.
Curious, what do you perceive to be your biggest bottlenecks over the next year?
I am a veterinarian and cannot express how much I would like to have a solution for these intractable case of stomatitis. Please let me know if there is anything I could do to help your trial.
Just a thought from my experience with Mirataz (transdermal mirtazapine ointment exclusively for feline appetite stimulation); is a topical route in the works? Here's a study suggesting CsA can be effectively administered this way: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780175/
Ah, my partner's cat has the exact disease you're targeting. What's the ETA on market availability? :-D
This was really interesting, thanks for the writeup! The idea of targeting animal drug approval before humans seem almost obvious after reading this, making me think that either 1) I'm missing some downsides, or 2) the drug development market just isn't very efficient.
Curious, what do you perceive to be your biggest bottlenecks over the next year?
I like cats but they may be net-negative (especially outside ones).
I am a veterinarian and cannot express how much I would like to have a solution for these intractable case of stomatitis. Please let me know if there is anything I could do to help your trial.
Just a thought from my experience with Mirataz (transdermal mirtazapine ointment exclusively for feline appetite stimulation); is a topical route in the works? Here's a study suggesting CsA can be effectively administered this way: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780175/